港股異動 | 丘鈦科技(1478.HK)大幅反彈超9% 9月攝像頭銷售同比增15%
格隆匯10月22日丨此前創10個月新低的丘鈦科技(1478.HK)近日開始反彈,現大幅拉昇漲超9%,報12.24港元,成交額放大至4985萬港元,總市值145億港元。公司日前公佈,9月攝像頭模組銷量合計4298.8萬件,同比增長15.2%,環比增長5.5%。其中,指紋識別模組銷售數量合計945.9萬件,同比增長12.3%。中金公司期待公司將其光學技術賦能更多智能終端,持續受益於消費電子類產品人工智能物聯網時代。另外,新汽車業務有望貢獻未來增量,公司重點推進與Tierl客户和、全球車廠的合作。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.